供应2024年08月归档第190页
- 2024-08-20 01:43抑制剂3-AP|3-AP|143621-35-6|Adamas life|≥98%(以实测数值为准)|BR|25mg
- 2024-08-20 01:43抑制剂3-AP|3-AP|143621-35-6|Adamas life|≥98%(以实测数值为准)|BR|5mg
- 2024-08-20 01:43抑制剂3,5-O-Dicaffeoylquinic acid|3,5-O-Dicaffeoylquinic acid|89919-62-0|Adamas life|≥98%(以实测数值为准)|BR|1
- 2024-08-20 01:43抑制剂3,5-O-Dicaffeoylquinic acid|3,5-O-Dicaffeoylquinic acid|89919-62-0|Adamas life|≥98%(以实测数值为准)|BR|2
- 2024-08-20 01:43抑制剂3,5-O-Dicaffeoylquinic acid|3,5-O-Dicaffeoylquinic acid|89919-62-0|Adamas life|≥98%(以实测数值为准)|BR|5
- 2024-08-20 01:43抑制剂3,6-Dichlorotrimellitic acid|3,6-Dichlorotrimellitic acid|137071-78-4|Adamas life|≥98%(以实测数值为准)|B
- 2024-08-20 01:43抑制剂2-HBA|2-HBA|131359-24-5|Adamas life|≥98%(以实测数值为准)|BR|100mg
- 2024-08-20 01:43抑制剂2-HBA|2-HBA|131359-24-5|Adamas life|≥98%(以实测数值为准)|BR|25mg
- 2024-08-20 01:43抑制剂2-HBA|2-HBA|131359-24-5|Adamas life|≥98%(以实测数值为准)|BR|5mg
- 2024-08-20 01:43抑制剂2',3'-cGAMP|2',3'-cGAMP|1441190-66-4|Adamas life|≥99%(以实测数值为准)|BR|5mg
- 2024-08-20 01:43抑制剂2′-O-(2-Methoxyethyl)guanosine|2′-O-(2-Methoxyethyl)guanosine|473278-54-5|Adamas life|≥98%(以实测数值为
- 2024-08-20 01:43抑制剂2′-O-(2-Methoxyethyl)guanosine|2′-O-(2-Methoxyethyl)guanosine|473278-54-5|Adamas life|≥98%(以实测数值为
- 2024-08-20 01:43抑制剂2′-O-(2-Methoxyethyl)guanosine|2′-O-(2-Methoxyethyl)guanosine|473278-54-5|Adamas life|≥98%(以实测数值为
- 2024-08-20 01:43抑制剂1-Oxo Ibuprofen|1-Oxo Ibuprofen|65813-55-0|Adamas life|≥98%(以实测数值为准)|BR|25mg
- 2024-08-20 01:43抑制剂1-Oxo Ibuprofen|1-Oxo Ibuprofen|65813-55-0|Adamas life|≥98%(以实测数值为准)|BR|5mg
- 2024-08-20 01:43抑制剂2',3'-cGAMP|2',3'-cGAMP|1441190-66-4|Adamas life|≥99%(以实测数值为准)|BR|1mg
- 2024-08-20 01:43抑制剂1-NM-PP1|1-NM-PP1|221244-14-0|Adamas life|≥98%(以实测数值为准)|BR|5mg
- 2024-08-20 01:43抑制剂1-Oxo Ibuprofen|1-Oxo Ibuprofen|65813-55-0|Adamas life|≥98%(以实测数值为准)|BR|1mg
- 2024-08-20 01:43抑制剂1-Linoleoyl Glycerol|1-Linoleoyl Glycerol|2277-28-3|Adamas life|≥98%(以实测数值为准)|BR|500mg
- 2024-08-20 01:43抑制剂1-NM-PP1|1-NM-PP1|221244-14-0|Adamas life|≥98%(以实测数值为准)|BR|100mg
首页 上一页 下一页 尾页